Medication Beliefs of P2Y12 Inhibitors on Twitter: An Exploratory Thematic and Semantic Analysis (Preprint)

Author:

Lee Jin SolORCID,Choi YongORCID,Heng Franklin,Tejuco Kyle,Kesarwani ManojORCID

Abstract

BACKGROUND

Approximately, 40% of patients are non-adherent to their P2Y12 inhibitors following percutaneous coronary intervention despite the increased risk for stent thrombosis and death. More research to better understand patient beliefs and attitudes of P2Y12 inhibitors is needed.

OBJECTIVE

Our objective was to use Twitter to analyze natural patient experiences of individuals using P2Y12 inhibitors.

METHODS

We collected public Twitter posts from Jan 01, 2016 to Dec 31, 2019 to identify posts related to an individual’s experience with taking P2Y12 inhibitors. Using conventional content analysis, we categorized each eligible post into key themes of adherence and further categorized each post into positive, negative, or neutral sentiments.

RESULTS

We identified 50,525 Twitter posts of which 366 met sufficient inclusion criteria. The CARRE concordance construct was developed identifying five core themes including Communication (4.7%), Affordability (25.4%), adverse drug Reactions (37.4%), patient perceived Response to treatment (11.5%), and E-(I)nconvenience with taking the medication (21%). Interestingly, 56% of the posts shared negative sentiments about taking P2Y12 inhibitors.

CONCLUSIONS

Our research is the first original investigation analyzing Twitter as a qualitative research medium to analyze individuals’ experiences using P2Y12 inhibitors. Our findings reinforced prior qualitative work using focus group interviews and surveys. Though social media offers the potential for large scale qualitative analysis with less social desirability and selection bias, we found that a key limitation includes a lack of structured investigation leading to the exclusion of many posts often missing important contextual information relevant to the research question.

CLINICALTRIAL

N/A

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3